Literature DB >> 35258768

Impact of the Ratio of Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer.

Makoto Sakai1, Makoto Sohda2, Shintaro Uchida1, Arisa Yamaguchi1, Takayoshi Watanabe1, Hideyuki Saito1, Yasunari Ubukata1, Nobuhiro Nakazawa1, Kengo Kuriyama1, Akihiko Sano1, Hiroomi Ogawa1, Takehiko Yokobori3, Ken Shirabe4, Hiroshi Saeki1.   

Abstract

BACKGROUND: The synergic effects of muscle mass reduction with excess body adiposity in surgically resected esophageal cancer (EC) patients remains controversial, especially in non-obese patients.
METHODS: One hundred and six patients with EC who underwent surgery between 2006 and 2014 were included in this study. Reduction in muscle mass and excess body adiposity were defined as the ratio of visceral fat area (VFA) to psoas muscle area (PMA) (V/P ratio) on the same axial computed tomography (CT) slice at the third lumbar vertebra (L3).
RESULTS: A high V/P ratio was associated with greater age (p = 0.03), higher body mass index (BMI) (p < 0.001), higher VFA (p < 0.001), and increased age-adjusted Charlson comorbidity index (ACCI) (p = 0.005). Multivariate analysis revealed a high V/P ratio to be an independent prognostic factor for poor overall survival (OS) in EC patients who underwent surgery (p = 0.003). The prognostic value of the V/P ratio was still significant in EC patients with a BMI < 25.
CONCLUSIONS: A high V/P ratio was associated with poor survival in surgically resected EC patients, even in non-obese patients. The V/P ratio as a surrogate marker of relative muscle mass reduction and fat accumulation may have prognostic value in EC patients regardless of body composition differences.
© 2022. Society of Surgical Oncology.

Entities:  

Keywords:  Computed tomography; Esophageal cancer; Fat accumulation; Muscle mass reduction; Prognosis

Year:  2022        PMID: 35258768     DOI: 10.1245/s10434-022-11497-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions.

Authors:  Valerie W Rusch; Thomas W Rice; John Crowley; Eugene H Blackstone; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04       Impact factor: 5.209

2.  Sarcopenic obesity: Time to meet the challenge.

Authors:  Rocco Barazzoni; Stephan C Bischoff; Yves Boirie; Luca Busetto; Tommy Cederholm; Dror Dicker; Hermann Toplak; Andre Van Gossum; Volkan Yumuk; Roberto Vettor
Journal:  Clin Nutr       Date:  2018-05-07       Impact factor: 7.324

Review 3.  Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.

Authors:  S Levolger; J L A van Vugt; R W F de Bruin; J N M IJzermans
Journal:  Br J Surg       Date:  2015-09-16       Impact factor: 6.939

4.  The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.

Authors:  Hou-Qun Ying; Qi-Wen Deng; Bang-Shun He; Yu-Qin Pan; Feng Wang; Hui-Ling Sun; Jie Chen; Xian Liu; Shu-Kui Wang
Journal:  Med Oncol       Date:  2014-10-30       Impact factor: 3.064

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

Authors:  Carla M M Prado; Jessica R Lieffers; Linda J McCargar; Tony Reiman; Michael B Sawyer; Lisa Martin; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2008-06-06       Impact factor: 41.316

7.  Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study.

Authors:  Makoto Sakai; Makoto Sohda; Hideyuki Saito; Yasunari Ubukata; Nobuhiro Nakazawa; Kengo Kuriyama; Keigo Hara; Akihiko Sano; Kyoichi Ogata; Takehiko Yokobori; Ken Shirabe; Hiroshi Saeki
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 8.  The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.

Authors:  Erika Aparecida Silveira; Rômulo Roosevelt da Silva Filho; Maria Claudia Bernardes Spexoto; Fahimeh Haghighatdoost; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

9.  Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.

Authors:  Kostan W Reisinger; Joanna W A M Bosmans; Martine Uittenbogaart; Abdulaziz Alsoumali; Martijn Poeze; Meindert N Sosef; Joep P M Derikx
Journal:  Ann Surg Oncol       Date:  2015-04-17       Impact factor: 5.344

10.  Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer.

Authors:  Wen-Shen Gu; Wei-Zhen Fang; Chun-Yue Liu; Kun-Yi Pan; Rui Ding; Xiao-Hui Li; Chao-Hui Duan
Journal:  Cancer Manag Res       Date:  2019-04-10       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.